Search Results 1061-1070 of 21714 for Inhibition

1. Treatment of Recurrent Clostridium Difficile Infection with RBX7455 - Mayo Clinic

   Agrees to stop proton pump inhibitors or H2 blocker medications. Agrees to practice a form of effective contraception during study participation. Has a ...

2. Beta-Blockers and Bone Health - Mayo Clinic

   ... inhibitors in past 12 months, or androgen blockers; Subjects who are not ambulatory. Participating Mayo Clinic locations. Study statuses change often. Please ...

3. Cabozantinib-s-malate or Sunitinib Malate in Treating Patients With Previously Untreated Locally Advanced or Metastatic Kidney Cancer - Mayo Clinic

   ... inhibitors; patients may not have received a strong CYP3A4 inducer within 12 days prior to registration nor a strong CYP3A4 inhibitor within 7 days prior to ...

4. Overview - Mitochondrial Neurobiology and Therapeutics Laboratory - Mayo Clinic Research

   For example, based on basic science research, our research team identified the inhibition of axonal trafficking of mitochondria as the underlying molecular ...

5. Placebo Controlled Study of VS-6063 in Subjects with Malignant Pleural Mesothelioma - Mayo Clinic

   Prior treatment with drugs an FAK inhibitor. Women who are pregnant or breastfeeding. Participating Mayo Clinic locations. Study statuses change often ...

6. Cyclophosphamide, Ixazomib, and Dexamethasone in Treating Patients With Previously Untreated Symptomatic Multiple Myeloma - Mayo Clinic

   Systemic treatment with strong inhibitors of cytochrome P450 1A2 (CYP1A2) (fluvoxamine, enoxacin, ciprofloxacin), strong inhibitors of cytochrome P450 3A4 ...

7. Safety and Efficacy Study of Pracinostat With Azacitadine in Elderly Patients With Newly Diagnosed Acute Myeloid Leukemia (AML) - Mayo Clinic

   Received prior histone deacetylase (HDAC) inhibitor or deacetylase (DAC) inhibitor is not permitted such as Istodax (romidepsin/depsipetide) or valproic acid.

8. Erlotinib Hydrochloride in Reducing Duodenal Polyp Burden in Patients With Familial Adenomatous Polyposis at Risk of Developing Colon Cancer - Mayo Clinic

   Use of potent CYP3A4 inhibitors ... Regular (≥ 2 times per week) use of drugs that alter the pH of the GI tract, such as proton pump inhibitors (PPI) and ...

9. Parkinson's disease - Diagnosis and treatment - Mayo Clinic

   Ask your healthcare professional before taking any other medicines with an MAO B inhibitor. Catechol O-methyltransferase, also called COMT, inhibitors. These ...

10. The Effect of Sucralfate Slurry in Patients With Eosinophilic Esophagitis - Mayo Clinic

    ... inhibitors. Exclusion criteria: Medical conditions such as severe heart or lung disease that preclude safe performance of endoscopy; Pregnant and lactating ...